CN113461579B - Preparation method of pharmaceutical grade dimethyl sulfoxide - Google Patents

Preparation method of pharmaceutical grade dimethyl sulfoxide Download PDF

Info

Publication number
CN113461579B
CN113461579B CN202110878994.7A CN202110878994A CN113461579B CN 113461579 B CN113461579 B CN 113461579B CN 202110878994 A CN202110878994 A CN 202110878994A CN 113461579 B CN113461579 B CN 113461579B
Authority
CN
China
Prior art keywords
dimethyl sulfoxide
tower
pressure
medicinal
micro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202110878994.7A
Other languages
Chinese (zh)
Other versions
CN113461579A (en
Inventor
贺妍
冷若菲
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
He Yan
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN202110878994.7A priority Critical patent/CN113461579B/en
Publication of CN113461579A publication Critical patent/CN113461579A/en
Application granted granted Critical
Publication of CN113461579B publication Critical patent/CN113461579B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C315/00Preparation of sulfones; Preparation of sulfoxides
    • C07C315/06Separation; Purification; Stabilisation; Use of additives
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/10Process efficiency

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)

Abstract

The application discloses a preparation method of medicinal dimethyl sulfoxide, which comprises the following steps: adding industrial-grade dimethyl sulfoxide with the content of more than 99.8% into a stainless steel rectifying still, then adding distilled water according to the proportion of 1. The preparation method has the characteristics of advanced production technology, controllable process conditions, simple and easily obtained auxiliary raw materials, low unit consumption and the like.

Description

Preparation method of pharmaceutical grade dimethyl sulfoxide
Technical Field
The invention belongs to the technical field of intermediate medicament preparation in the field of medicines, and particularly relates to a preparation method of medicinal dimethyl sulfoxide.
Background
The medical grade dimethyl sulfoxide is an important solvent in the medical industry, can be directly used as a raw material or a carrier of a medicament, has the efficacies of diminishing inflammation, relieving pain, promoting urination, calming and the like, is known as 'universal medicine', and has wide application in the medical field, such as:
dimethyl sulfoxide can quickly penetrate skin and permeate medicine into organism, and is clinically used as a penetrant;
the dimethyl sulfoxide has the effects of diminishing inflammation, relieving pain, promoting urination and quickly reducing swelling, and plays a role in absorbing and enhancing organic solvents such as antibiotics, hormones and the like;
the dimethyl sulfoxide has the function of absorbing water and has the effect of eliminating various edemas, hydrops and herpes;
because the effective components of dimethyl sulfoxide can be extracted from Chinese herbs, dimethyl sulfoxide is well regarded by the traditional Chinese medicine.
Due to the particularity of the field of medicine, the requirements on the purity, cleanliness and ultraviolet absorbance of the medical-grade dimethyl sulfoxide are very high. In the prior art, the application of the medical-grade dimethyl sulfoxide is limited by the requirements and the limits of content impurities and ultraviolet light absorption values, and the medical-grade dimethyl sulfoxide cannot be utilized from industrial-grade dimethyl sulfoxide, so that the medical-grade dimethyl sulfoxide in China depends on import for a long time, has high price and cannot be popularized and used in a large area. In the traditional dimethyl sulfoxide (non-medicinal grade) preparation methods, such as CN102093268A and CN106674066A, an intermediate medium needs to be added, new impurities are introduced, so that the requirements of medicinal grades cannot be met, and CN104119256A has the problems of complex preparation device and high generation cost.
Disclosure of Invention
The application aims to provide a preparation method of medicinal dimethyl sulfoxide, which can realize the preparation of the medicinal dimethyl sulfoxide at low cost by means of a simple device, is convenient and quick to generate, and greatly improves the processing speed.
The technical purpose of the invention is realized by the following technical scheme:
a preparation method of medicinal dimethyl sulfoxide comprises the following steps:
1) Pumping industrial grade dimethyl sulfoxide with the content of more than 99.8 percent into a stainless steel rectifying kettle under the condition of reduced pressure, and metering;
2) Adding distilled water according to the mass ratio of 1;
3) Under the condition of reduced pressure, the pressure at the top of the tower is controlled to be 6-8 Kpa at the temperature of 42-46 ℃, the pressure at the bottom of the tower is controlled to be 8.5-11.5 Kpa at the temperature of 80-90 ℃, and part of impurities in dimethyl sulfoxide are carried out by water extracted from the top of the tower;
4) After all the water in the rectifying still is extracted, when the dimethyl sulfoxide is extracted, the temperature of the top of the tower is 102-105 ℃, the pressure of the top of the tower is 8-10 Kpa, the temperature of the bottom of the tower is 120-125 ℃, and the pressure of the bottom of the tower is 11.5-12.5 Kpa, and the dimethyl sulfoxide is extracted from the top of the tower into an intermediate tank;
5) The extracted dimethyl sulfoxide passes through a micro-membrane by a pressure pump in an intermediate tank under the protection of nitrogen;
6) And (3) carrying out ion exchange on the dimethyl sulfoxide passing through the micro-membrane and the pretreated resin by using a peristaltic pump under the protection of nitrogen to prepare medicinal dimethyl sulfoxide, putting the medicinal dimethyl sulfoxide into a finished product tank, and packaging.
Further, in step 5), the pore size of the micro-membrane is 0.2 μm, and dimethyl sulfoxide is passed through the micro-membrane using a pressure pump.
Further, in step 6), the resin comprises a positive and a negative resin, and ion exchange is performed by chromatography using a peristaltic pump.
Furthermore, the preparation process of the pharmaceutical grade dimethyl sulfoxide can not contact with air, and the whole process is carried out under the protection of nitrogen.
Further, the content of dimethyl sulfoxide prepared by the method is 99.95%.
Further, when nitrogen gas was introduced for 15 minutes, the absorbance values at 275nm, 285nm and 295nm were measured as 0.281, 0.602 and 0.418, respectively.
Compared with the prior art, the invention has the following advantages:
the medicinal dimethyl sulfoxide prepared by the method has the characteristics of high purity, less impurities, ultraviolet light absorption value reaching pharmacopeia standards, easily obtained raw materials, low unit consumption, easy operation of the process and the like. The detection result completely reaches the 2020 standard of Chinese pharmacopoeia.
Drawings
In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings used in the description of the embodiments or the prior art will be briefly described below, and it is obvious that the drawings in the following description are some embodiments of the present invention, and those skilled in the art can also obtain other drawings according to the drawings without creative efforts.
FIG. 1 is a process flow diagram of the process for preparing pharmaceutical grade dimethyl sulfoxide according to the present application.
Detailed Description
In order to make the technical solutions of the present invention better understood and make the above features, objects, and advantages of the present invention comprehensible, the present invention is further explained with reference to examples, and it should be noted that all examples listed herein are only illustrative and are not meant to limit the scope of the present invention.
As shown in figure 1, the preparation method of the pharmaceutical grade dimethyl sulfoxide comprises the steps of putting industrial grade dimethyl sulfoxide with the content of more than 99.8% into a stainless steel rectifying still, metering, putting distilled water into the rectifying still according to a ratio of 1.
Comparative example 1:
putting more than 99.8% of industrial-grade dimethyl sulfoxide into a stainless steel rectifying kettle, metering, putting common water into the rectifying kettle according to a ratio of 1. And (3) taking out all dimethyl sulfoxide in the rectifying kettle, then feeding the dimethyl sulfoxide into an intermediate tank, filtering the dimethyl sulfoxide through a 3M micro-membrane by using a pressure pump under the protection of nitrogen, then carrying out ion exchange on the dimethyl sulfoxide and pretreated anion-cation resin by using a peristaltic pump, and feeding the prepared medicinal dimethyl sulfoxide into a finished product tank. The prepared medicinal dimethyl sulfoxide is sampled, the content of the medicinal dimethyl sulfoxide is 99.88 percent through gas chromatography detection, and after the medicinal dimethyl sulfoxide is subjected to nitrogen for 15 minutes, the light absorption values at 275nm, 285nm and 295nm are respectively measured to be 0.556, 0.771 and 0.505. According to the standard of '2020 version of Chinese pharmacopoeia', the light absorption values of 275nm, 285nm and 295nm wavelength are not more than 0.3, 0.65 and 0.45, and do not accord with the standard of medical grade dimethyl sulfoxide.
Comparative example 2:
putting more than 99.8% of industrial-grade dimethyl sulfoxide into a stainless steel rectifying kettle, metering, putting distilled water into the rectifying kettle according to a ratio of 1. And (3) extracting all dimethyl sulfoxide in the rectifying kettle, introducing the dimethyl sulfoxide into an intermediate tank, under the protection of nitrogen, introducing the dimethyl sulfoxide into pretreated cation-anion resin by using a peristaltic pump for exchange to obtain medicinal dimethyl sulfoxide, and introducing the medicinal dimethyl sulfoxide into a finished product tank. Sampling the prepared medicinal dimethyl sulfoxide, detecting the content of 99.90% by gas chromatography, and passing nitrogen through the medicinal dimethyl sulfoxide for 15 minutes to respectively measure the light absorption values of 275nm, 285nm and 295nm wavelength as 0.352, 0.404 and 0.273. According to the standard of '2020 version of Chinese pharmacopoeia', the light absorption values of 275nm, 285nm and 295nm wavelength are not more than 0.3, 0.65 and 0.45, and do not accord with the standard of medical grade dimethyl sulfoxide.
Comparative example 3:
putting more than 99.8% of industrial-grade dimethyl sulfoxide into a stainless steel rectifying kettle, metering, putting distilled water into the rectifying kettle according to a ratio of 1. And (3) extracting all dimethyl sulfoxide in the rectifying kettle, introducing the dimethyl sulfoxide into an intermediate tank, filtering the dimethyl sulfoxide through a 3M micro-membrane by using a pressure pump under the protection of nitrogen, and introducing the prepared medicinal dimethyl sulfoxide into a finished product tank. Sampling the prepared medicinal dimethyl sulfoxide, detecting the content of 99.92% by gas chromatography, introducing nitrogen for 15 min for replacement, and respectively measuring the light absorption values of 275nm, 285nm and 295nm as 0.328, 0.685 and 0.482. According to the standard of '2020 version of Chinese pharmacopoeia', the light absorption values of 275nm, 285nm and 295nm wavelength are not more than 0.3, 0.65 and 0.45, and do not accord with the standard of medical grade dimethyl sulfoxide.
Example 1:
putting more than 99.8% of industrial-grade dimethyl sulfoxide into a stainless steel rectifying kettle, metering, putting distilled water into the rectifying kettle according to a ratio of 1. And (4) extracting all dimethyl sulfoxide in the rectifying kettle to enter an intermediate tank. Filtering dimethyl sulfoxide by a pressure pump through a 3M micro-membrane under the protection of nitrogen, performing ion exchange on the dimethyl sulfoxide through pretreated anions and cations by a peristaltic pump to obtain medicinal dimethyl sulfoxide, and putting the medicinal dimethyl sulfoxide into a finished product tank. Sampling the prepared medicinal dimethyl sulfoxide, detecting the content of 99.95% by gas chromatography, introducing nitrogen for 15 minutes, and respectively measuring the light absorption values of 275nm, 285nm and 295nm as 0.281, 0.602 and 0.418. According to the standard of '2020 version of Chinese pharmacopoeia', the light absorption values of 275nm, 285nm and 295nm wavelength are not more than 0.3, 0.65 and 0.45, and the standard accords with the pharmaceutical grade dimethyl sulfoxide, and the product is packaged after the detection is qualified.
Summarizing the above embodiments, the following conclusions can be drawn:
the quality requirements of raw materials and auxiliary materials in the preparation process of the medicinal dimethyl sulfoxide are quite high, and the medicinal dimethyl sulfoxide prepared by adopting distilled water and then filtering through a 3M micro-membrane and exchanging through anion-cation resin meets the standard of '2020 edition of Chinese pharmacopoeia' and can completely meet the requirements of customers.
Finally, it should be noted that: the above examples are only intended to illustrate the technical solution of the present invention, and not to limit it; although the present invention has been described in detail with reference to the foregoing embodiments, it will be understood by those of ordinary skill in the art that: the technical solutions described in the foregoing embodiments may still be modified, or some technical features may be equivalently replaced; and such modifications or substitutions do not depart from the spirit and scope of the corresponding technical solutions of the embodiments of the present invention.

Claims (5)

1. The preparation method of the medicinal grade dimethyl sulfoxide is characterized by comprising the following steps:
1) Pumping industrial grade dimethyl sulfoxide with the content of more than 99.8 percent into a stainless steel rectifying kettle under the condition of reduced pressure, and metering;
2) Adding distilled water according to the mass ratio of 1;
3) Under the condition of reduced pressure, the pressure at the top of the tower is controlled to be 6-8 Kpa at the temperature of 42-46 ℃, the pressure at the bottom of the tower is controlled to be 8.5-11.5 Kpa at the temperature of 80-90 ℃, and part of impurities in dimethyl sulfoxide are carried out by water extracted from the top of the tower;
4) After all the water in the rectifying still is extracted, when the dimethyl sulfoxide is extracted, extracting the dimethyl sulfoxide from the top of the tower to an intermediate tank, wherein the temperature at the top of the tower is 102-105 ℃, the pressure at the top of the tower is 8-10 Kpa, the temperature at the bottom of the tower is 120-125 ℃, and the pressure at the bottom of the tower is 11.5-12.5 Kpa;
5) The extracted dimethyl sulfoxide passes through a micro-membrane by a pressure pump in an intermediate tank under the protection of nitrogen;
6) And (3) carrying out ion exchange on the dimethyl sulfoxide passing through the micro-membrane and the pretreated resin by using a peristaltic pump under the protection of nitrogen to prepare medicinal dimethyl sulfoxide, putting the medicinal dimethyl sulfoxide into a finished product tank, and packaging.
2. The method of claim 1, wherein in step 5), the pore size of the micro-membrane is 0.2 μm, and the dimethyl sulfoxide is passed through the micro-membrane by using a pressure pump.
3. The method for preparing pharmaceutical grade dimethylsulfoxide according to claim 1, wherein, in step 6), the resin comprises two resins of a cation and a anion, and the ion exchange is carried out by chromatography using a peristaltic pump.
4. The method of claim 1, wherein the pharmaceutical grade dimethylsulfoxide is prepared without contact with air and the whole process is carried out under nitrogen protection.
5. The method of claim 1, wherein the dimethyl sulfoxide has a dimethyl sulfoxide content of 99.95%.
CN202110878994.7A 2021-08-02 2021-08-02 Preparation method of pharmaceutical grade dimethyl sulfoxide Active CN113461579B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110878994.7A CN113461579B (en) 2021-08-02 2021-08-02 Preparation method of pharmaceutical grade dimethyl sulfoxide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110878994.7A CN113461579B (en) 2021-08-02 2021-08-02 Preparation method of pharmaceutical grade dimethyl sulfoxide

Publications (2)

Publication Number Publication Date
CN113461579A CN113461579A (en) 2021-10-01
CN113461579B true CN113461579B (en) 2023-04-11

Family

ID=77883748

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110878994.7A Active CN113461579B (en) 2021-08-02 2021-08-02 Preparation method of pharmaceutical grade dimethyl sulfoxide

Country Status (1)

Country Link
CN (1) CN113461579B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115784952B (en) * 2022-10-09 2024-07-05 新疆兴发化工有限公司 Purification process of electronic grade dimethyl sulfoxide

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102093268A (en) * 2010-12-29 2011-06-15 天津市康科德科技有限公司 Preparation method of chromatographic grade dimethyl sulfoxide
CN107459472B (en) * 2016-06-03 2019-08-02 中国石油天然气股份有限公司 Method for refining dimethyl sulfoxide solvent in carbon fiber precursor production process
CN106674066B (en) * 2016-12-09 2020-05-05 国药集团化学试剂有限公司 Dimethyl sulfoxide purification method
CN112225680A (en) * 2019-07-15 2021-01-15 中国石油化工股份有限公司 Organic solvent purification method and device

Also Published As

Publication number Publication date
CN113461579A (en) 2021-10-01

Similar Documents

Publication Publication Date Title
CN113461579B (en) Preparation method of pharmaceutical grade dimethyl sulfoxide
CN104311688A (en) Method for extracting and separating dendrobium nobile polysaccharide and total alkali
CN1282654C (en) Process for preparing astraglus base total saponin
CN104987516A (en) Preparation method for pH intelligent response membrane with nano-crystalline cellulose for enhancing tara gum substrate
CN113398622A (en) Supercritical CO2Method for preparing wormwood raw pulp by extraction and molecular distillation processes
CN106967036B (en) Preparation method of EGCG
CN104013612A (en) Method for preparing glabridin beta-cyclodextrin clathrate compound
CN110066349B (en) Low-molecular-weight blackberry polysaccharide and preparation method thereof
CN108250320A (en) A kind of low ash content ganoderan extract and preparation method thereof
CN108888669B (en) Preparation method of oral liquid for clearing heat and relieving cough of children
CN102633900A (en) Method for extracting and purifying polysaccharide from Cordyceps militaris
Zhang et al. Optimizing the extraction of catechin from peanut red skin using response surface methodology and its antioxidant activity
CN104740555A (en) Preparation process and application of mulberry-ginger extract
CN104771713A (en) Mulberry-ginger extract, and preparation process and application thereof
CN114057907B (en) Method for extracting, separating and purifying red ginseng polysaccharide
CN103145871B (en) The preparation method of cherry polysaccharide
CN102224923B (en) Preparation method of modified apple polyphenol
CN106045959B (en) A kind of method that glucosidase procyanidins are prepared using grape seed extract
CN113200823A (en) Preparation method of benzyl alcohol with low peroxide value
CN107739306B (en) A method for preparing refined herba Rosmarini officinalis extract
CN107098985B (en) A method for extracting acidic polysaccharides from residue of radix Ginseng after ethanol extraction
CN110559370A (en) preparation process for improving quality of traditional Chinese medicine extracting solution
CN104055840B (en) The process for purification of motherwort extract solution
CN107126461B (en) Preparation process of water-soluble stephania tetrandra extract
CN116889598B (en) Preparation method of Jiangzhiping oral liquid and its products and use

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
CB02 Change of applicant information
CB02 Change of applicant information

Address after: 201799 No. 1999, Beixing Road, Sanxing Town, Qingpu District, Shanghai (Shanghai yuhaitang science and Technology Park)

Applicant after: Shanghai Demai Shiou Technology Co.,Ltd.

Address before: No.1999 Beixing Road, Sanxing Town, Chongming District, Shanghai 202150 (yuhaitang Science Park, Shanghai)

Applicant before: Shanghai Demai Shiou Chemical Co.,Ltd.

CB02 Change of applicant information
CB02 Change of applicant information

Address after: 201799 room 4014, science and technology incubation service center, 1155 Gongyuan East Road, Qingpu District, Shanghai

Applicant after: Shanghai Demai Shiou Technology Co.,Ltd.

Address before: 201799 No. 1999, Beixing Road, Sanxing Town, Qingpu District, Shanghai (Shanghai yuhaitang science and Technology Park)

Applicant before: Shanghai Demai Shiou Technology Co.,Ltd.

GR01 Patent grant
GR01 Patent grant
TA01 Transfer of patent application right
TA01 Transfer of patent application right

Effective date of registration: 20230329

Address after: 124000 Hexiang Community, Chuangxin Street, Xinglongtai District, Panjin City, Liaoning Province, A-8-1-502

Applicant after: He Yan

Address before: 201799 room 4014, science and technology incubation service center, 1155 Gongyuan East Road, Qingpu District, Shanghai

Applicant before: Shanghai Demai Shiou Technology Co.,Ltd.